Herein, we report a series of pyridines and their sulfa drug derivatives as antimicrobial agents. Regioselective alkylation followed by hydrozinolysis of 2-pyridone 1 gave the target compounds 2 and 3 . Compound 3 was cyclized with acetylacetone or heated in dry benzene to give 2-(pyrazol-1-yl)nicotinonitrile 5 and 3-amino-1 H -pyrazolo[3,4- b ]pyridine derivatives 6 , respectively. Diazotization of compound 3 with nitrous acid at low temperature afforded tetrazolo[1,5- a ]pyridine derivative 8 . Compounds 6 and 7 were obtained by condensation of hydrazine derivative 3 with D -glucose and D -ribose. Acid-mediated hydrolysis and sulfurization of dicyano compound 2 gave pyridine-3,5-dicarboxamide 11 and 2-thioxopyridine 12 derivatives, respectively. The later compound was alkylated with allyl bromide, benzyl chloride and mono chloroacetic acid to produce the corresponding S-alkylated derivatives 13 – 15 . Compound 15 underwent the Thrope–Ziegler cyclization/condensation with sulfa-drugs to give the corresponding thienopyridine 16 and sulfonamide derivatives 17 – 19 . Antimicrobial study of the new syntheized compounds demonstrated signficant activity of compounds 8 – 11 and 17 – 19 .
No takes yet. Share an insight, caveat, or question.
El‐Sayed et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: